<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36753012</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Egyptian adaptation and validation of the Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS-EG).</ArticleTitle><Pagination><StartPage>1871</StartPage><EndPage>1880</EndPage><MedlinePgn>1871-1880</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-023-06639-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is the most common, fatal adult neuromuscular disease. It is a multi-system disorder characterized primarily by motor manifestations, but there is established evidence for cognitive and behavioral impairment, which is associated with poor prognosis, hence, the importance of tools for its assessment. The Edinburgh Cognitive and Behavioral Assessment Screen (ECAS) is an invaluable assessment tool for cognition in ALS-front temporal spectrum dementia (FTSD), as it accommodates physical challenges that usually confound traditional neuropsychological testing in those patients.</AbstractText><AbstractText Label="OBJECTIVE AND METHODS" NlmCategory="OBJECTIVE">To validate the Egyptian Arabic version of ECAS (ECAS-EG) based on the original English scale. This is a prospective study. The ECAS was adapted and administered to 62 Egyptian ALS patients and 60 healthy controls. Patients were recruited from the Neuromuscular Unit, Ain Shams University Hospital. The ECAS was adapted to Egyptian Arabic after being translated using the back translation method. Internal consistency of the test, inter-rater reliability, and construct validity were assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The Egyptian Arabic version of ECAS (ECAS-EG) showed good internal consistency using Cronbach's alpha of 0.84. Inter-rater reliability was tested, values for all variables were compared, and no statistically significant differences were found (ICC = .997). ECAS-EG discriminated significantly between the patients from the control subjects (p-value of 0.001). There was a strong positive correlation between the ECAS-EG total score and the MoCA total score with a p-value of 0.001, thus indicating convergent validity. The test showed that 63% of Egyptian ALS patients were cognitively affected; most affected domains were executive functions and verbal fluency.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The current study proves that the Egyptian version of the ECAS (ECAS-EG) is valid and reliable among Egyptian ALS patients and it would be applicable to the general Arabic-speaking population.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Soliman</LastName><ForeName>Radwa</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1280-1764</Identifier><AffiliationInfo><Affiliation>Neuromuscular Unit, Neurology and Psychiatry Department, Faculty of Medicine, Ain Shams University, Cairo, 11566, Egypt. radwasoliman@med.asu.edu.eg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rashed</LastName><ForeName>Hebatallah R</ForeName><Initials>HR</Initials><Identifier Source="ORCID">0000-0001-6154-806X</Identifier><AffiliationInfo><Affiliation>Neuromuscular Unit, Neurology and Psychiatry Department, Faculty of Medicine, Ain Shams University, Cairo, 11566, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moustafa</LastName><ForeName>Ramez R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Neuromuscular Unit, Neurology and Psychiatry Department, Faculty of Medicine, Ain Shams University, Cairo, 11566, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamdi</LastName><ForeName>Nabila</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Molecular Pathology Unit, German University in Cairo (GUC), Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swelam</LastName><ForeName>Mahmoud S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Neuromuscular Unit, Neurology and Psychiatry Department, Faculty of Medicine, Ain Shams University, Cairo, 11566, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osman</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3506-8254</Identifier><AffiliationInfo><Affiliation>Biotechnology Department, Basic and Applied Sciences Institute, Egypt-Japan University of Science and Technology, Borg Al Arab, 21934, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biochemistry Department, Faculty of Science, Ain Shams University, Cairo, 11566, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fahmy</LastName><ForeName>Nagia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8670-0419</Identifier><AffiliationInfo><Affiliation>Neuromuscular Unit, Neurology and Psychiatry Department, Faculty of Medicine, Ain Shams University, Cairo, 11566, Egypt. dr.nagiafahmy@med.asu.edu.eg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="Y">Cognition Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004534" MajorTopicYN="N" Type="Geographic">Egypt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">ALSFTD</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cognitive</Keyword><Keyword MajorTopicYN="N">ECAS</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>11</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36753012</ArticleId><ArticleId IdType="pmc">PMC10175416</ArticleId><ArticleId IdType="doi">10.1007/s10072-023-06639-6</ArticleId><ArticleId IdType="pii">10.1007/s10072-023-06639-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Longinetti E, Wallin AR, Samuelson K, et al. The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:528&#x2013;537. doi: 10.1080/21678421.2018.1497065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1497065</ArticleId><ArticleId IdType="pubmed">30296856</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun KY, Park J, Oh KW, et al. Epidemiology of ALS in Korea using nationwide big data. J Neurol Neurosurg Psychiatry. 2019;90:395&#x2013;403. doi: 10.1136/jnnp-2018-318974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318974</ArticleId><ArticleId IdType="pmc">PMC6581156</ArticleId><ArticleId IdType="pubmed">30409890</ArticleId></ArticleIdList></Reference><Reference><Citation>Turgut N, Birgili O, VarolSaracoglu G, et al. An epidemiologic investigation of amyotrophic lateral sclerosis in Thrace, Turkey, 2006&#x2013;2010. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:100&#x2013;106. doi: 10.1080/21678421.2018.1525403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1525403</ArticleId><ArticleId IdType="pubmed">30468083</ArticleId></ArticleIdList></Reference><Reference><Citation>Leighton DJ, Newton J, Stephenson LJ, et al. Changing epidemiology of motor neurone diseases in Scotland. J Neurol. 2019;266:817&#x2013;825. doi: 10.1007/s00415-019-09190-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09190-7</ArticleId><ArticleId IdType="pubmed">30805795</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury A, Mukherjee A, Sinharoy U, Pandit A, Biswas A. Non-motor features of amyotrophic lateral sclerosis: a clinic-based study. Ann Indian Acad Neurol. 2021;24(5):745&#x2013;753. doi: 10.4103/aian.AIAN_51_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aian.AIAN_51_21</ArticleId><ArticleId IdType="pmc">PMC8680868</ArticleId><ArticleId IdType="pubmed">35002134</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Graaff MM, de Jong JM, Baas F, de Visser M. Upper motor neuron and extra-motor neuron involvement in amyotrophic lateral sclerosis: a clinical and brain imaging review. Neuromuscul Disord. 2009;19:53&#x2013;8. doi: 10.1016/j.nmd.2008.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2008.10.002</ArticleId><ArticleId IdType="pubmed">19070491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586&#x2013;590. doi: 10.1212/01.wnl.0000172911.39167.b6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000172911.39167.b6</ArticleId><ArticleId IdType="pubmed">16116120</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, Halliday GM, Kril JJ, et al. The frontotemporal dementia&#x2013;motor neuron disease continuum. Lancet. 2016;388(10047):919&#x2013;931. doi: 10.1016/S0140-6736(16)00737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00737-6</ArticleId><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral scleroris: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368&#x2013;80. doi: 10.1016/S1474-4422(13)70026-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70026-7</ArticleId><ArticleId IdType="pubmed">23518330</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S. ALS, cognition and the clinic. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:3&#x2013;5. doi: 10.3109/21678421.2013.760149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.760149</ArticleId><ArticleId IdType="pubmed">23316701</ArticleId></ArticleIdList></Reference><Reference><Citation>Lule&#xb4; D, Burkhardt C, Abdulla S, Bo&#xa8;hm S, Kollewe K, Uttner I et al (2015) The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Front Degener 16:16&#x2013;23. 10.3109/21678421.2014.959451</Citation><ArticleIdList><ArticleId IdType="pubmed">25292386</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, Monti A, Zago S, Calini D, Tiloca C, Doretti A, Verde F, Ratti A, Ticozzi N, Abrahams S, Silani V. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS) Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(7&#x2013;8):489&#x2013;498. doi: 10.1080/21678421.2016.1183679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1183679</ArticleId><ArticleId IdType="pubmed">27219526</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora JS, Salas T, Fern&#xe1;ndez MC, Rodr&#xed;guez-Castillo V, Mar&#xed;n S, Chaverri D, Rodr&#xed;guez-Santos F. Spanish adaptation of the Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS) Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(1&#x2013;2):74&#x2013;79. doi: 10.1080/21678421.2017.1406952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1406952</ArticleId><ArticleId IdType="pubmed">29212378</ArticleId></ArticleIdList></Reference><Reference><Citation>Taulea T, Morlanda AS, Rens&#xe5;c MA, A&#xdf;musd J, Tysnesc O, Rekand T. Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS) in Norway: protocol for validation and a prospective cohort study. Contemp Clin Trials Commun. 2019;14:100347. doi: 10.1016/j.conctc.2019.100347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conctc.2019.100347</ArticleId><ArticleId IdType="pmc">PMC6444026</ArticleId><ArticleId IdType="pubmed">30976725</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye S, Li C, Liu X, et al. The Edinburgh cognitive and behavioural ALS screen in a Chinese amyotrophic lateral sclerosis population. PLOS One. 2016;11(5):1&#x2013;11. doi: 10.1371/journal.pone.0155496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0155496</ArticleId><ArticleId IdType="pmc">PMC4873026</ArticleId><ArticleId IdType="pubmed">27195772</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezd&#xed;&#x10d;ek&#xa0;O,&#xa0;Markov&#xe1;&#xa0;L,&#xa0;So&#xf3;sov&#xe1;&#xa0;N et al (2018) Czech version of the Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen &#x2013; a pilot study. Cesk Slov Neurol N 81/114(2):208&#x2013;212</Citation></Reference><Reference><Citation>De Icaza Valenzuela MM, Bak TH, Thompson HE, Colville S, Pal S, Abrahams S. Validation of The Edinburgh cognitive and behavioural ALS screen (ECAS) in behavioural variant frontotemporal dementia and Alzheimer&#x2019;s disease. Int J Geriatr Psychiatry. 2021;36(10):1576&#x2013;1587. doi: 10.1002/gps.5566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5566</ArticleId><ArticleId IdType="pubmed">33983668</ArticleId></ArticleIdList></Reference><Reference><Citation>Kacem I, Abida Y, Ferchichi W, Mrabet S, Sghaier I, Gharbi A, Souissi A, Nasri A, Gargouri A, Ben Djebara M, Gouider R (2022) Arabic adaptation of the Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS-AR). Rev Neurol (Paris) S0035-3787(22):00556&#x2013;2. 10.1016/j.neurol.2021.12.015</Citation><ArticleIdList><ArticleId IdType="pubmed">35570063</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, B&#xe9;dirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695&#x2013;9. doi: 10.1111/j.1532-5415.2005.53221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman TT, El Gaafary MM. Montreal Cognitive Assessment Arabic version: reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. Geriatr Gerontol Int. 2009;9:54&#x2013;61. doi: 10.1111/j.1447-0594.2008.00509.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1447-0594.2008.00509.x</ArticleId><ArticleId IdType="pubmed">19260980</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashed HR, Tork MA, Soliman R, Serag R, Fahmy N (2020) Arabic adaptation and validation of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R): Egyptian study. Amyotroph Lateral Scler Frontotemporal Degener p.&#xa0;0:1&#x2013;3.&#xa0;10.1080/21678421.2020.1815788</Citation><ArticleIdList><ArticleId IdType="pubmed">32897109</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Newton J, Niven E, Foley J, Bak TH (2014) Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 15(1&#x2013;2):9&#x2013;14. 10.3109/21678421.2013.805784. Accessed Jan 2019</Citation><ArticleIdList><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grise D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS) Neuropsychologia. 2000;38:734&#x2013;747. doi: 10.1016/S0028-3932(99)00146-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0028-3932(99)00146-3</ArticleId><ArticleId IdType="pubmed">10689049</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockford C, Newton J, Lonergan K, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91:e1370&#x2013;e1380. doi: 10.1212/WNL.0000000000006317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006317</ArticleId><ArticleId IdType="pmc">PMC6177274</ArticleId><ArticleId IdType="pubmed">30209236</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufouil C, Alpe&#xb4;rovitch A, Tzourio C. Influence of education on the relationship between white matter lesions and cognition. Neurology. 2003;60:831&#x2013;6. doi: 10.1212/01.wnl.0000049456.33231.96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000049456.33231.96</ArticleId><ArticleId IdType="pubmed">12629242</ArticleId></ArticleIdList></Reference><Reference><Citation>Crockford C, Kleynhans M, Wilton E, Radakovic R, Newton J, Niven E, Al-Chalabi A, Hardiman O, Bak TH, Abrahams S (2017) Amyotrophic lateral sclerosis and frontotemporal degeneration. 1&#x2013;8. 10.1080/21678421.2017.1407793</Citation><ArticleIdList><ArticleId IdType="pubmed">29205065</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>